As spine surgery technology advances, researchers are studying new devices, techniques and applications.
Here are three studies to know:
1. 3Spine is conducting a trial for its Motus system, which is currently under FDA investigational device exemption. The 50th case in the study was completed in March. 3Spine's lumbar total joint replacement procedure and Motus device is a new technology, replacing the function of the disc and facet joints through a posterior approach. The technique reconstructs the functional spinal unit, like a hip or knee total joint replacement. 3Spine is still recruiting clinical trial patients for the study but is expecting U.S. approval of Motus by 2025.
2. Centinel Spine finished enrollment for a 2-level Investigational Device Exemption trial for the Prodisc C Vivo and Prodisc C SK disc replacement devices. The trial will include 431 patients across 29 sites in the U.S., according to a news release. The IDE trial is the first to allow surgeons to select from two different disc replacement devices to treat each level.
3. Aurora Spine earned Institutional Review Board approval to begin a multicenter study of its Dexa-C cervical interbody system. The Dexa-C system uses Aurora Spine's patented color-coded implants which come in varyinh densities to match a patient's bone density, according to a news release. The device is designed for anterior cervical discectomy and fusions. Aurora Spine's study will span up to 10 sites and enroll at least 40 single-level and 40-multi-level patients. Outcomes are expected to be measured at three months, six months and 12 months post-surgery.